Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has announced it will validate the NOVAprep® liquid-based cytology platform with Abbott’s RealTime High Risk HPV (Human papillomavirus) assay. Download press release
Visit PageYear: 2015
Novacyt Named in Deloitte Technology Fast 500
Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has been named in the Deloitte Technology Fast 500 for Europe, Middle East and Africa. Download press release
Visit PageNovacyt Named in Deloitte Technology Fast 50
Novacyt (ALTERNEXT: ALNOV), an international specialist in cancer and infectious disease diagnostics, has been named in the Deloitte Technology Fast 50 in France. Download press release
Visit Page